Search results
US FDA approves ImmunityBio's bladder cancer therapy
AOL· 3 days ago(Reuters) -The U.S. health regulator approved on Monday ImmunityBio's combination therapy to treat a type of bladder cancer, marking an end to the company's efforts to bring its therapy to the ...
EU approves BeiGene's tislelizumab for lung cancer By Investing.com
Investing.com· 2 days agoThe European Commission (EC) has granted approval to tislelizumab for the treatment of non-small...
Farmers urged to have “urgent“ discussions about the future
Cosmos· 5 days agoDr Katherine Wynn, CSIRO Futures’ Agriculture and Food Lead, says the report “should serve as a call...
12 Warren Buffett Quotes Every 30-Year-Old Needs To Hear
247wallst.com· 3 days agoBuffett’s practical investment strategy looks to buy into solid but undervalued companies with the...
Opinion | Ukraine Aid in the Light of History
New York Times· 2 days agoOn Saturday the House of Representatives finally overcame MAGA opposition and approved a new aid package for Ukraine. The Biden administration presumably...
16 Ways People Survived Before Social Security — Could You Do It?
GOBankingRates via Yahoo Finance· 1 day agoEnacted in 1935, Social Security has been one of the most successful programs in U.S. history....
Jazz Pharmaceuticals to Present Data Across Growing Oncology Pipeline and Portfolio at ASCO 2024
FOX 59 Indianapolis· 19 hours agoJazz Pharmaceuticals plc (Nasdaq: JAZZ) today announced that the company, along with its partners, will present or publish eight abstracts at the American Society of Clinical Oncology (ASCO) ...
I’m a doctor — here’s what to know about rising cancer rates in young people
NY Post via Yahoo News· 7 days agoOcean also advised that if you can, talk to your family and get details about your medical history....
Detecting cancer in minutes possible with just a drop of dried blood and new test, study hints
LiveScience· 3 days agoA new AI-powered test could one day be used to accurately and quickly detect three major types of...
BioVie Presents Data Showing Potential for Bezisterim (NE3107) to Reduce Inflammation and Restore...
Morningstar· 3 hours ago“Bezisterim” has been approved as the non-proprietary name for NE3107Data shows how bezisterim may be restoring homeostasis via specific genes associated with dementia, metabolism, and inflammation CARSON CITY, Nev., April 25, 2024
